Scientists find cause of debilitating eye disease 15-year effort points to treatments to help MacTel patients and offers potential new insights into other eye diseases
September 11, 2019
LA JOLLA, CA Scientists at Scripps Research, the Lowy Medical Research Institute (LMRI) and collaborating research organizations have discovered one cause of a progressive, debilitating eye disease called macular telangiectasia type 2 (MacTel). The work, using genetic, clinical and biochemical studies has implications for other retinal eye diseases, as well as peripheral neuropathies.
This is a breakthrough not just for MacTel research, but for eye, neurological, and metabolic research more broadly, said Martin Friedlander, president of LMRI, professor at Scripps Research, and senior author on the paper with Christian Metallo, an associate professor at University of California, San Diego and Paul Bernstein, a professor at University of Utah School of Medicine. This discovery was only made possible through a global network of talented collaborating physicians, scientists and patients; generously supported by enlightened philanthropists, the Lowys.
The research was published by the New England Journal of Medicine on September 11, 2019.
Worldwide, MacTel is estimated to affect about 2 million people, with an onset of symptoms typically occurring in the fourth and fifth decades of life. A disease of the retina, the light-sensing tissue at the back of the eye, MacTel causes those affected to experience a gradual deterioration of central vision, interfering with such critical tasks as reading and driving. There is currently no treatment for the disease.
For the last 15 years, a group of scientists has been working in a highly focused international effort to find the disease's cause and develop effective treatments. Early efforts to use genetics to determine the cause were frustrated by the disease's association with a multitude of genes.
However, a unique multi-faceted approach that involved networks of patients and scientists, using not only genetics but also metabolomics, suggested the disease was associated with low blood levels of serine. Serine is an amino acid used in many pathways in the body, but not previously known to affect macular health.
In the current paper, LMRI researchers show that low serine levels in MacTel patients lead to an accumulation of toxic lipids, deoxysphingolipids, which causes photoreceptor cell death.
A clue that led to this discovery came from a family that included two people affected by both MacTel and a rare peripheral neuropathy, hereditary sensory and autonomic neuropathy 1 (HSAN1), known to be caused by toxic deoxysphingolipids. The clinicians then conducted comprehensive eye exams on a group of 13 HSAN1 patients and found the majority also had MacTel.
Deoxysphingolipids are toxic to neurons in other parts of the body, but no one knew if these lipids also play a role in eye disease, said Marin Gantner, LMRI scientist and co-first author on the paper with LMRI scientist Kevin Eade and UC San Diego postdoctoral fellow Martina Wallace. Thanks to clues provided by patients with both MacTel and HSAN1, we hypothesized the low serine we've seen in MacTel patients could be causing the body to make toxic lipids that damage the eye.
Biochemically, this made sense. If serine levels are low, the enzyme responsible for sphingolipid production will use alanine instead, which results in deoxysphingolipid production. The scientists expanded their research to a broad population of MacTel patients who did not have HSAN1, and found that low serine in MacTel patients is correlated with high deoxysphingolipid levels. The researchers confirmed in mice that low serine leads to elevated deoxysphingolipid levels in the blood, retina, and peripheral nerves. This affected the sensory system of the mice, reducing peripheral and retinal nerve function.
In this case, a single biochemical mechanism causes disease in both the eye and the peripheral nervous system, said Friedlander. We think this is an example of a new class of neurodegenerative disease that we are calling serineopathy,' and may have application to more common metabolic and neurological disorders.
Bringing the research back to humans, the scientists used retinal organoids made from human induced pluripotent stem cells (iPSC) to confirm that deoxysphingolipids are toxic to human retinal tissue.
Recent advances in stem cell research have given us the ability to make human retinal tissue, called retinal organoids, in the lab. These retinal organoids mimic the human retina, said Eade. They allow us to investigate the cause of retinal diseases and test the effect of drugs directly on the human retina.
The group found that adding the prescription lipid-lowering medication fenofibrate to retinal organoids that have been exposed to deoxysphingolipids protects against photoreceptor cell death. Fenofibrate has been shown to stimulate the breakdown of deoxysphingolipids.
LMRI's unique research model is at the center of these discoveries. The Institute brings together a highly collaborative group of scientists and clinicians from around the world, and facilitates the exchange of information through regular meetings. Patient-based research is central to the model; the Institute supports a MacTel patient registry and coordinates access to patient-derived tissues for research. The Lowy Medical Research Institute is supported by the generosity of the Lowy family, and is an example of how philanthropy can advance rare disease research.
The next steps in the research are to discover how widespread the role of deoxysphingolipids is in causing macular disease and to characterize the pathways that lead to elevated deoxysphingolipids in MacTel.
The authors of the study, Serine and Lipid Metabolism in M
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
04/08/2026
Dalet, a leading technology and service provider for media-rich organizations, t...
04/07/2026
April 7 2026, 19:00 (PDT) Detective Conan: Fallen Angel of the Highway Opens in...
01/06/2026
January 6 2026, 05:30 (PST) Dolby Sets the New Standard for Premium Entertainment at CES 2026
Throughout the week, Dolby brings to life the latest innovatio...
08/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
08/05/2026
Liberty University on why broadcast technology isn't just a technical invest...
08/05/2026
COW Jobs: UGC, On-Camera Video Content
Brie Clayton May 7, 2026
0 Comments
UGC, On-Camera Video Content
April 17, 2026Documentary Editor - US,......
07/05/2026
Journalists reporting on Sudan are working in one of the most complex and fast-m...
07/05/2026
Multi-year partnership positions Victory+ as a free home for Dallas Cowboys orig...
07/05/2026
From sideline reporting to directing and producing, the talented sophomore is building a well-rounded foundation for a career in live sports production
In the ...
07/05/2026
Cobalt Digital has received two Future Best of Show awards at NAB Show 2026. The COBALT blueCORE platform was recognized by TV Tech, and the COBALT PACIFIC ULL-...
07/05/2026
ESPN analyst Mina Kimes will host the televised semifinals and finals of the 202...
07/05/2026
Bitmovin has announced that MUBI, the global film streaming platform, has selected Bitmovin as its cloud VOD encoding partner. Bitmovin's encoding infrastru...
07/05/2026
NBCUniversal Telemundo Enterprises and the U.S. Soccer Federation have announced...
07/05/2026
Angel City Football Club (ACFC) and Victory have announced a regional broadcast partnership bringing live match coverage to fans across the greater Los Angeles...
07/05/2026
Spiideo has announced the launch of AI Highlights inside Spiideo Play, its automated sports production platform. AI Highlights combines video, event data, audio...
07/05/2026
Leostream Corporation has announced a unified remote access ecosystem for high-p...
07/05/2026
The Atlanta Dream has partnered with Victory to stream all locally broadcast Dream games for free, expanding the team's digital distribution strategy and g...
07/05/2026
Riedel Communications has announced the appointment of Marc Engroff as Chief Fin...
07/05/2026
SES and ARD, Germany's largest public broadcasting network, have announced a long-term extension of their satellite distribution partnership through 2039. U...
07/05/2026
UpLight Technologies delivers a flexible video and lighting system for a new televised sportLaunching the Pro Cheer League required more than creating a compell...
07/05/2026
Full Day Productions and GSE Worldwide have announced Spikes Under the Lights, a...
07/05/2026
Seit dem Start im Jahr 2023 hat DJ (Beta) das personalisierte H rerlebnis von 94...
07/05/2026
Da quando stata presentata nel 2023, DJ (beta) ha aiutato a definire un'esperienza d'ascolto pi personalizzata per 94 milioni di utenti Spotify Premi...
07/05/2026
Since launching in 2023, DJ (beta) has helped shape a more personalized listenin...
07/05/2026
Desde o lan amento em 2023, o DJ (beta) j ajudou a deixar a experi ncia de ouvi...
07/05/2026
From our earliest days, Spotify has been built on a simple principle: Great audio should be easy to reach. It's what's driven us to expand from music to...
07/05/2026
Asian and Pacific Islander artists continue to shape the global soundscape, pushing creative boundaries and connecting with fans worldwide. This Asian & Pacific...
07/05/2026
Company announce long-requested choir instrument
In the latest expansion of their Symphonic Elements series, UJAM have introduced an all-new vocal instrumen...
07/05/2026
Modular-inspired sound generation with digital control
Buchla have introduced Ziggy, a new compact synthesizer built around the company's complex oscill...
07/05/2026
Combines analogue voices with digital synthesis and sequencing
Polyend have announced Drums, a new hybrid analogue and digital drum machine that combines sy...
07/05/2026
Control surface now officially supports four DAWs
When Nektar launched the Panorama CS12 control surface, it worked exclusively with Apple's Logic Pro, ...
07/05/2026
In the first quarter 2026, SGL Carbon generated consolidated sales of 184.5 million, which was 49.8 million, or 21.3%, lower than in the prior year (Q1 2025: ...
07/05/2026
Rohde & Schwarz and Greenerwave achieve precise and fast ESA antenna characteriz...
07/05/2026
Two multi-role L3Harris products - the Red Wolf launched effects vehicle and SK...
07/05/2026
L3Harris will be developing key features of a secure and resilient digital infra...
07/05/2026
Alysa Liu and Shohei Ohtani Help Drive Viewership as 91 of the Top 100 Broadcast...
07/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
07/05/2026
Cobalt Digital Wins Two Future Best of Show Awards at 2026 NAB Show
Manufacturer Recognized by TV Tech and TVBEurope for Innovation in signal processing
Cobal...
07/05/2026
Software and hardware platforms, AI power and user-friendliness on show...
07/05/2026
Intinor will demonstrate its latest technical enhancements for the Direkt series at BroadcastAsia 2026. With a continued focus on reliable contribution and remo...
07/05/2026
Bitmovin has announced that MUBI has chosen Bitmovin as its cloud VOD encoding partner, replacing MUBI's legacy on premises encoding setup to improve scalab...
07/05/2026
Meet Graduates from Berklees Class of 2026 Members of this years graduating class reflect on their proudest moments at Berklee and look ahead to whats next.
...
07/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
07/05/2026
At BroadcastAsia 2026, Interra Systems will demonstrate its latest innovations in automated quality control (QC), real-time monitoring, and captioning. The comp...
07/05/2026
At this year's Broadcast Asia, PlayBox Neo is set to unveil recent innovations across its PlayBox Neo Suite and integrated range of broadcast media solution...
Scientists find cause of debilitating eye disease 15-year effort points to treatments to help MacTel patients and offers potential new insights into other eye diseases
